Effect of chemical modification strategy on the characteristics of copper-67-labeled immunoconjugates. Part I: Immunoreactivity

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 1, 1997, Pages 1-12

  Bhalgat, Mahesh K ^a   Roberts, Jeanette C ^a   Mercer Smith, Janet A ^b   Vessella, Robert L ^c   Lavallee, David K ^d  

^a UNIVERSITY OF UTAH   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Antibody delivery; Antibody fragments; Copper 67; F(ab')2; Immunoreactivity; Porphyrin chelators; Renal cell arcinoma; Starburst dendrimers; Targeting

Indexed keywords

ANTIBODY; ANTIBODY CONJUGATE; CHELATING AGENT; COPPER 67; COPPER CHELATING AGENT; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A6H; N (4 NITROBENZYL) 5 (4 CARBOXYPHENYL) 10,15,20 TRIS(4 SULFOPHENYL)PORPHINE; N BENZYL 5,10,15,20 TETRAKIS(4 CARBOXYPHENYL)PORPHINE; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY CELL; PRIORITY JOURNAL;

EID: 0030903727     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709033181     Document Type: Article

References (53)

1. Abraham, R., Moller, D., Gabel, D., Senter, P., Hellstrom, I., and Hellstrom, K. E. (1991) The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity. J. Immunol. Methods 144, 77-86.
2. Arano, Y., Inoue, T., Mukai, T., Wakisaka, K., Sakahara, H., Konishi, J., and Yokoyama, A. (1994) Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody. J. Nucl. Med. 35, 326-333.
3. Atassi, M. Z. (1967) Periodate oxidation of sperm-whale myoglobin and the role of the methionine residues in the antigen-antibody. Biochem J. 102, 478-187.
4. Azari, P., and Phillips, J. L. (1970) Action of periodate on ovotransferrin and its metal complexes. Arch. Biochem. Biophys. 138, 32-38.
5. Barth, R. F., and Soloway, A. H. (1994) Boron neutron capture therapy of primary and metastatic brain tumors. Mol. Chem. Neuropathol. 21, 139-154.
6. Barth, R. F., Adams, D. M., Soloway, A. H., and Darby, M. V. (1994) Boronated Starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjugate Chem. 5, 58-66.
7. Bhalgat, M. K., and Roberts, J. C. (1997) Molecular modeling of polyamidoamine (PAMAM) Starburst dendrimers. Macromolecules, submitted.
8. Bhalgat, M. K., Roberts, J. C., Mercer-Smith, J. A., Knotts, B. D., Vessella, R. L., and Lavallee, D. K. (1997a) Preparation and biodistribution of copper-67 labeled porphyrins and porphyrin-A6H immunoconjugates. Nucl. Med. Biol., in press.
9. Bhalgat, M. K., Roberts, J. C., Mercer-Smith, J. A., Vessella, R. L., and Lavallee, D. K. (1997b) Effect of chemical modification strategy on the characteristics of copper-67 labeled immunoconjugates. II. Aggregation. Drug Deliv., 4, 13-17.
10. Caneva, E., Di Gennaro, P., Farina, F., Orlandi, M., and Rindone, B. (1993) Synthesis and characterization of a penicillin-poly(L-lysine) which recognizes human IgE anti-penicillin antibodies. Bioconjugate Chem. 4, 309-313.
11. 2 fragments. J. Urol. 142, 1584-1588.
12. Chiou, R. K., Vessella, R. L., Limas, C., Shafer, R. B., Elson, M. K., Arfman, E. W., and Lange, P. H. (1988) Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model. Cancer 61, 1766-1775.
13. del Rosario, R. B., Wahl, R. L., Brocchini, S. J., Lawton, R. G., and Smith, R. H. (1990) Sulfhydryl site-specific cross-linking and labeling of monoclonal antibodies by a fluorescent equilibrium transfer alkylation cross-link reagent. Bioconjugate Chem. 1, 51-59.
14. DeNardo, S. J., DeNardo, G. L., Peng, J. S., and Colcher, D. (1983) Monoclonal antibody radiopharmaceuticals for cancer radioimmunotherapy. In "Radioimmunoimaging and Radioimmunotherapy" (S. W. Burchiel and B. Rhodes, Eds.), pp. 409-117. Elsevier Scientific, New York.
15. Ellman, G. L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
16. Fisch, I., Kunzi, G., Rose, K., and Offord, R. (1992) Site-specific modification of a fragment of a chimeric monoclonal antibody using reverse proteolysis. Bioconjugate Chem. 3, 147-153.
17. Gansow, O. A., Wu, C., and Brechbiel, M. (1994) Dendrimer-based metal chelates: Linkage to monoclonal antibodies as isotope carriers in radioimmunotherapy. ABST 24, Division of Nuclear Chemistry and Technology, 208th ACS National Meeting, August 21-25, Washington, DC.
18. Griffiths, G. L., Goldenberg, D. M., Knapp, F. F., Jr., Callahan, A. P., Chang, C. H., and Hansen, H. J. (1991) Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: Labeling and animal biodistribution studies. Cancer Res. 51, 4594-4602.
19. Griffiths, G. L., Goldenberg, D. M., Jones, A. L., and Hansen, H. J. (1992) Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Bioconjugate Chem. 3, 91-99.
20. Herlyn, D., Powe, J., Ross, A. H., Herlyn, M., and Koprowski, H. (1985) Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. J. Immunol. 134, 1300-1304.
21. 2 fragments. Nucl. Med. Biol. 13, 401-405.
22. Laemmli, U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
23. Lavallee, D. K., White, A., Diaz, A., Battioni, J. P., and Mansuy, D. (1986) Efficient metalloporphyrin synthesis under mild conditions using N-benzyl porphyrins. Tetrahedron Lett. 27, 3521-3524.
24. Liu, L., Barth, R. F., Adams, D. M., Soloway, A. H., and Reisfeld, R. A. (1995) Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. J. Hematotherapy 4, 477-483.
25. Mach, J. P., Chatal, J. F., Lumbroso, Y. D., Buchegger, I., Fomi, M., Ritshard, J., Berche, C., Douillard, J. Y., Carrel, S., Herlyn, M., Steplewski, Z., and Koprowski, H. (1983) Tumor localization in patients by radiolabeled monoclonal antibodies. Cancer Res. 43, 5593-5600.
26. Mather, S. J., and Ellison, D. (1990) Reduction-mediated technetium-99m labeling of monoclonal antibodies. J. Nucl. Med. 31, 692-697.
27. Mercer-Smith, J. A., Roberts, J. C., Figard, S. D., and Lavallee, D. K. (1988) The development of copper-67-labeled porphyrin-antibody conjugates. In "Antibody-Mediated Delivery Systems" (J. D. Rodwell, Ed.), pp. 317-352. Marcel Dekker, New York.
28. Mercer-Smith, J. A., Cole, D. A., Roberts, J. C., Lewis, D., Behr, M. J., and Lavallee, D. K. (1990) The biodistribution of radiocopper-labeled compounds. In "Copper Bioavailability and Metabolism" (C. Kies, Ed.), pp. 103-121. Plenum, New York.
29. Mercer-Smith, J. A., Roberts, J. C., Lewis, D., Cole, D. A., Newmyer, S. L., Schulte, L. D., Mixon, P. L., Schreyer, S. A., Figard, S. D., Burns, T. P., McCormick, D. J., Lennon, V. A., Hayashi, M., and Lavallee, D. K. (1991) Radiometallating antibodies and autoantigenic peptides. In "New Trends in Radiopharmaceutical Syntheses, Quality Assurance, and Regulatory Control" (A. M. Emran, Ed.), pp. 129-152. Plenum, New York.
30. Millan, J. C. (1989) Tumors of the kidney. In "Uropathology," Vol. 2 (G. S. Hill, Ed.), pp. 623-701. Churchill Livingstone, New York.
31. Moon, T. D., Vessella, R. L., Palme, D. F., Nowak, J. A., and Lange, P. H. (1985) A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody. Hybridoma 4, 163-171.
32. 2 in colorectal cancer patients. Cancer 73, 850-857.
33. Nisonoff, A., Harper, J. E., and Spring, S. R. (1975) "The Antibody Molecule." Academic Press, New York.
34. Packard, B., Edidin, M., and Komoriya, A. (1986) Site-directed labeling of a monoclonal antibody: Targeting to a disulfide bond. Biochemistry 25, 3548-3552.
35. Pietersz, G. A. (1990) The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer. Bioconjugate Chem. 1, 89-95.
36. Pimm, M. V., Rajput, R. S., Frier, M., and Gribben, S. J. (1991) Anomalies in reduction-mediated technetium-99m labeling of monoclonal antibodies. Eur. J. Nucl. Med. 18, 973-976.
37. 67Cu. Nucl. Phys. A 131, 393-397.
38. Rhodes, B. A., Zamora, P. O., Newell, K. D., and Valdez, E. F. (1986) Technetium-99m labeling of murine monoclonal antibody fragments. J. Nucl. Med. 27, 685-693.
39. Roberts, J. C., Figard, S. A., Mercer-Smith, J. A., Svitra, Z. V., Andersen, W. L., and Lavallee, D. K. (1987) Preparation and characterization of copper-67 porphyrin-antibody conjugates. J. Immunol. Methods 105, 153-164.
40. Roberts, J. C., Newmyer, S. L., Mercer-Smith, J. A., Schreyer, S. A., and Lavallee, D. K. (1989) Labeling antibodies with copper radionuclides using N-4-nitrobenzyl-5-(4-carboxyphenyl)-10,15,20-tris(4-sulfophenyl)porphine. Int. J. Radiat. Appl. Instrum. A 40, 775-781.
41. Roberts, J. C., Adams, Y. E., Tomalia, D., Mercer-Smith, J. A., and Lavallee, D. K. (1990) Using Starburst dendrimers as linker molecules to radiolabel antibodies. Bioconjugate Chem. 1, 305-307.
42. ™ dendrimers. J. Biomed. Mater. Res. 30, 53-65.
43. Rodwell, J. D., Alvarez, V. L., Lee, C., Lopes, A. D., Goers, J. W., King, H. D., Powsner, H. J., and McKearn, T. J. (1986) Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluation. Proc. Natl. Acad. Sci. USA 83, 2632-2636.
44. Ryan, E. M., O'Kennedy, R., Feeney, M. M., Kelly, J. M., and Vos, J. G. (1992) Covalent linkage of ruthenium polypyridyl compounds to poly(L-lysine), albumins, and immunoglobulin G. Bioconjugate Chem. 3, 285-290.
45. 2, and Fab′ conjugated to Pseudomonas exotoxin. Bioconjugate Chem. 3, 302-307.
46. Tomalia, D. A., Naylor, A. M., and Goddard, W. A., III (1990) Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. Engl. 29, 138-175.
47. Toyokuni, T., Hakomori, S., and Singhal, A. K. (1994) Synthetic carbohydrate vaccines: Synthesis and immunogenicity of Tn antigen conjugates. Bioorg. Med. Chem. 2, 1119-1132.
48. Vessella, R. L., Moon, T. D., Chiou, R., Nowak, J. A., Arfman, E. W., and Palme, D. F. (1985) Monoclonal antibodies to human renal cell carcinoma: Recognition of shared and restricted tissue antigens. Cancer Res. 45, 6131-6139.
49. Vessella, R. L., Lange, P. H., Palme, D. F., Chiou, R. K., Elson, M. K., and Wessels, B. W. (1988) Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice. In "Antibody-Mediated Delivery Systems" (J. D. Rodwell, Ed.), pp. 245-282. Marcel Dekker, New York.
50. Wessels, B. W., and Rogus, R. D. (1984) Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. Med. Phys. 11, 638-645.
51. Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., and Lauterbur, P. C. (1994) Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 31, 1-8.
52. 2. Nucl. Med. Biol. 20, 917-927.
53. 2 fragments. Bioconjugate Chem. 5, 220-235.